首页> 外文期刊>Arthritis research & therapy. >Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: Evidence from MyEIRA study and meta-analysis
【24h】

Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: Evidence from MyEIRA study and meta-analysis

机译:肽亚精氨酸脱亚氨酶的多态性与亚洲不同人群的类风湿性关节炎相关:来自MyEIRA研究和荟萃分析的证据

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: The majority of our knowledge regarding disease-related mechanisms of uncontrolled citrullination and anti-citrullinated protein antibody development in rheumatoid arthritis (RA) was investigated in Caucasian populations. However, peptidylarginine deiminase (PADI) type 4 gene polymorphisms are associated with RA in East Asian populations and weak or no association was found in Caucasian populations. This study explores the association between the PADI4 polymorphisms and RA risk in a multiethnic population residing in South East Asia with the goal of elucidating generalizability of association in non-Caucasian populations.Methods: A total of 320 SNPs from the PADI locus (including PADI1, PADI2, PADI3, PADI4 and PADI6 genes) were genotyped in 1,238 RA cases and 1,571 control subjects from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA) case-control study. Additionally, we conducted meta-analysis of our data together with the previously published studies of RA from East Asian populations.Results: The overall odds ratio (ORoverall) for the PADI4 (rs2240340) allelic model was 1.11 (95% confidence interval (CI) = 1.00 to 1.23, P = 0.04) and for the genotypic model was 1.20 (95% CI = 1.01 to 1.44, P = 0.04). Haplotype analysis for four selected PADI4 SNPs revealed a significant association of one with susceptibility (P = 0.001) and of another with a protective effect (P = 0.02). The RA susceptibility was further confirmed when combined meta-analysis was performed using these data together with data from five previously published studies from Asia comprising 5,192 RA cases and 4,317 control subjects (ORoverall= 1.23 (95% CI = 1.16 to 1.31, Pheterogeneity= 0.08) and 1.31 (95% CI = 1.20 to 1.44, Pheterogeneity= 0.32) in allele and genotype-based models, respectively). In addition, we also detected a novel association of PADI2 genetic variant rs1005753 with RA (ORoverall= 0.87 (95% CI = 0.77 to 0.99)).Conclusion: Our study demonstrates an association between PADI4 and RA in the multiethnic population from South East Asia and suggests additional association with a PADI2 gene. The study thus provides further support for the notion that polymorphisms in genes for enzymes responsible for citrullination contribute to RA development in multiple populations of Asian descent.
机译:简介:我们在白种人人群中研究了关于风湿性关节炎(RA)中不受控制的瓜氨酸化和抗瓜氨酸化蛋白抗体发展的疾病相关机制的大多数知识。然而,在东亚人群中,肽酰精氨酸脱亚氨酶(PADI)的4型基因多态性与RA相关,而在高加索人群中则没有关联或弱关联。本研究探讨了居住在东南亚多种族人群中PADI4多态性与RA风险之间的关联,旨在阐明非高加索人群中关联的普遍性。方法:来自PADI基因座(包括PADI1,在马来西亚风湿性关节炎流行病学调查(MyEIRA)病例对照研究中,对1,238例RA病例和1,571例对照受试者进行了基因分型(PADI2,PADI3,PADI4和PADI6基因)。此外,我们对数据进行了荟萃分析,并与先前发表的来自东亚人群的RA进行了研究。结果:PADI4(rs2240340)等位基因模型的总体比值比(ORoverall)为1.11(95%置信区间(CI)) = 1.00至1.23,P = 0.04),对于基因型模型为1.20(95%CI = 1.01至1.44,P = 0.04)。对四个选定的PADI4 SNP的单倍型分析显示,一个与敏感性(P = 0.001)和另一个与保护作用(P = 0.02)显着相关。使用这些数据以及来自亚洲的5篇先前发表的研究的数据进行合并荟萃分析,进一步证实了RA的敏感性,这些研究包括5192例RA病例和4,317例对照受试者(OR总体= 1.23(95%CI = 1.16至1.31,光生性= 0.08) )和1.31(在基于等位基因和基因型的模型中,分别为95%CI = 1.20至1.44,遗传多样性= 0.32)。此外,我们还检测到PADI2遗传变异rs1005753与RA的新型关联(ORoverall = 0.87(95%CI = 0.77至0.99))。结论:我们的研究表明,在东南亚多种族人群中PADI4与RA之间存在关联。并暗示与PADI2基因的其他关联。因此,该研究为以下观点提供了进一步的支持:负责瓜氨酸化的酶的基因基因多态性有助于亚洲后裔的多个人群中RA的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号